Rexahn Pharma (RNN): Niche in Pancreatic Cancer Looks Promising - FBR
Tweet Send to a Friend
FBR Capital analyst, Vernon Bernadino, reiterated his Outperform rating on shares of Rexahn Pharmaceuticals Inc. (NYSE: RNN) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE